Syngene International has incorporated wholly owned subsidiary company namely ‘Syngene Manufacturing Solutions’ (SMSL) on August 26, 2022. SMSL shall be engaged in the business of manufacturing of pharmaceutical, biopharmaceutical and biological products of any kind. The company has acquired is 10 lakh equity shares of Rs 10 each aggregating to Rs 1 crore.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
